新生儿持续肺动脉高压最新治疗进展(4)
[17]黄海波，刘海英，易璐，等.前列地尔联合常频通气治疗新生儿持续肺动脉高压疗效观察[J].中国实用儿科杂志，2012，27(12)：940-941.
[18] Mei M，Cheng G，Sun B，et al.EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension[J].Scientific Reports，2016，6(1)：29877.
[19] More K，Athalye-Jape G K，Rao S C，et al.Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants：Reviews[M].Cochrane Database of Systematic Reviews.Cochrane Database Syst Rev，2016.
[20] Steinhorn R H，Fineman J，Kusic-Pajic A，et al.Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn：Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial[J].The Journal of Pediatrics，2016(177)：90-96.
[21] Maneenil G，Thatrimontrichai A，Janjindamai W，et al.Effect of bosentan therapy in persistent pulmonary hypertension of the newborn[J].Pediatrics & Neonatology，2017，59(1)：58-64.
[22]洪小楊，周更须，李秋平，等.体外膜肺氧合技术在新生儿呼吸衰竭中的应用[J].中国小儿急救医学，2014，21(10)：629-632.
[23] K?ssel H，Bauer K，Kewitz G，et al.Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide？[J].Intensive Care Med，2000，26(10)：1489-1495.
[24] Nakwan N，Chaiwiriyawong P.An international survey on persistent pulmonary hypertension of the newborn：A need for an evidence-based management[J].Journal of Neonatal-Perinatal Medicine，2016，9(3)：243-250.
[25] Jonas P，Hedegaard E R，Ulf S，et al.Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn[J].Basic & Clinical Pharmacology & Toxicology，2018，123(4)., 百拇医药(朱玲)
[18] Mei M，Cheng G，Sun B，et al.EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension[J].Scientific Reports，2016，6(1)：29877.
[19] More K，Athalye-Jape G K，Rao S C，et al.Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants：Reviews[M].Cochrane Database of Systematic Reviews.Cochrane Database Syst Rev，2016.
[20] Steinhorn R H，Fineman J，Kusic-Pajic A，et al.Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn：Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial[J].The Journal of Pediatrics，2016(177)：90-96.
[21] Maneenil G，Thatrimontrichai A，Janjindamai W，et al.Effect of bosentan therapy in persistent pulmonary hypertension of the newborn[J].Pediatrics & Neonatology，2017，59(1)：58-64.
[22]洪小楊，周更须，李秋平，等.体外膜肺氧合技术在新生儿呼吸衰竭中的应用[J].中国小儿急救医学，2014，21(10)：629-632.
[23] K?ssel H，Bauer K，Kewitz G，et al.Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide？[J].Intensive Care Med，2000，26(10)：1489-1495.
[24] Nakwan N，Chaiwiriyawong P.An international survey on persistent pulmonary hypertension of the newborn：A need for an evidence-based management[J].Journal of Neonatal-Perinatal Medicine，2016，9(3)：243-250.
[25] Jonas P，Hedegaard E R，Ulf S，et al.Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn[J].Basic & Clinical Pharmacology & Toxicology，2018，123(4)., 百拇医药(朱玲)